Mashup Score: 70
American Society of HematologyKey Points. LIT plus venetoclax is associated with favorable post-transplant outcomes in older adults with AML (2-year OS 72%)Type of induction did not impact
Mashup Score: 70
American Society of HematologyKey Points. LIT plus venetoclax is associated with favorable post-transplant outcomes in older adults with AML (2-year OS 72%)Type of induction did not impact
In older pts with #AML, low-intensity therapy + ven followed by SCT 2-year OS of 72% and lower NRM than intensive chemo. LIT + ven induction is good option even for SCT-eligible pts. @NicholasShortMD @MDAndersonNews #Leukemia https://t.co/gdzpppIdf9 #leusm https://t.co/gdzpppIdf9 - view on twitter